Unlocking chemical matter on scale

webinar

Tue, 07 Jul 2020, 17:00 CEST (Berlin)

Dr. Serghei Glinca, CEO Crystals First GmbH, Marburg, Germany

Unlocking chemical matter on scale

Fragment-based lead discovery (FBLD) has undoubtedly become an invaluable resource for medicinal chemists in the identification of lead candidates.

Since an efficient fragment evolution requires structural data of protein-ligand interactions, a variety of biophysical methods are applied in a cascade approach as a set of prefilter prior to structure determination. Systematic studies suggest that the cascade approach significantly reduces the hit rate compared to a direct crystallographic screening.

The application of X-ray crystallography as a primary fragment screening method has been underutilized due to the limited availability of a robust system for soaking experiments and solubility issues of fragments. One of major bottlenecks in the experimental setup for crystal soaking is the sensitivity of protein crystals. We overcome this limitation using the SmartSoak® technology, which stabilizes protein crystals leading to high-performance soaking systems. No trial-and-error optimization of the soaking system needed.

In case studies, we demonstrate the advantages of the application of crystallographic fragment screening as a primary screening strategy for the hit identification. The resulting structural data can now be utilized to explore the chemical space on scale using computational methods.

Current news

category
Events
DrugSpace 2026 Symposium - The Path to Digital Chemistry
October 6, 2026 11:28 CEST
Where Medicinal and Computational Chemistry Come Together We are delighted to invite drug hunters, compound enthusiasts, and molecule designers back to the virtual DrugSpace Symposium. The fifth edition takes place on December 9, 2026, under the theme “The Path to Digital Chemistry,” and turns the spotlight on where computational and...
Read on
category
Events
BioSolveIT at the Enamine Drug Discovery Conference 2026 in Riga
September 23, 2026 16:21 CEST
The Enamine Drug Discovery Conference in Riga (Latvia) comes to a close today. Our CEO Dr. Christian Lemmen and our SVP Application Science Dr. Marcus Gastreich spent the past four days, 20 to 23 September 2026, at the Radisson Blu Latvija Conference & Spa Hotel, and they return with much...
Read on
VAST Just Got Bigger — The September 2026 Update
September 17, 2026 09:00 CEST
More compounds. More chemistry. More opportunities to discover your next active. This August, explore Enamine’s largest compound catalog with infiniSee xREAL as BioSolveIT’s Tool of the Month. XtalPi has expanded its VAST Chemical Space, giving you access to almost six billion virtual product molecules built from over 25,000 carefully selected...
Read on